4.8 Article

IL-23 promotes TCR-mediated negative selection of thymocytes through the upregulation of IL-23 receptor and RORγt

Journal

NATURE COMMUNICATIONS
Volume 5, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms5259

Keywords

-

Funding

  1. VA Merit Review Grant [1I01BX000600-01]
  2. NIH/NIAID [1AI 071110, ARRA 3RO1AI71110-02S1, 1RO1 AI083705]
  3. Rheumatology Research Foundation
  4. Lupus Research Institute
  5. Arthritis Foundation

Ask authors/readers for more resources

Transient thymic involution is frequently found during inflammation, yet the mode of action of inflammatory cytokines is not well defined. Here we report that interleukin-23 (IL-23) production by the thymic dendritic cells (DCs) promotes apoptosis of the CD4(hi)CD8(hi) double-positive (DP) thymocytes. A deficiency in IL-23 signalling interferes with negative selection in the male D-b/H-Y T-cell receptor (TCR) transgenic mice. IL-23 plus TCR signalling results in significant upregulation of IL-23 receptor (IL-23R) expressed predominantly on CD4(hi)CD8(hi)CD3(+) alpha beta TCR+ DP thymocytes, and leads to ROR gamma t-dependent apoptosis. These results extend the action of IL-23 beyond its peripheral effects to a unique role in TCR-mediated negative selection including elimination of natural T regulatory cells in the thymus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

The Gut Microbiota: Emerging Evidence in Autoimmune Diseases

Xuan Zhang, Bei-di Chen, Li-dan Zhao, Hao Li

TRENDS IN MOLECULAR MEDICINE (2020)

Article Immunology

IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice

Huixian Hong, Min Gao, Qi Wu, Philomena Yang, Shanrun Liu, Hao Li, Peter D. Burrows, Daniel Cua, Jake Y. Chen, Hui-Chen Hsu, John D. Mountz

JOURNAL OF IMMUNOLOGY (2020)

Article Rheumatology

Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis

Takayuki Katsuyama, Hao Li, Suzanne M. Krishfield, Vasileios C. Kyttaris, Vaishali R. Moulton

Summary: The study reveals a previously unrecognized role of SRSF1 in restraining IFN-gamma production and Th1 differentiation through the control of RhoH. Reduced expression of SRSF1 may contribute to the pathogenesis of autoimmune-related nephritis through these molecular mechanisms.

RHEUMATOLOGY (2021)

Review Rheumatology

Double-negative T cells in autoimmune diseases

Hao Li, George C. Tsokos

Summary: DNT cells, as a principal subset of mature T lymphocytes, have been closely linked with autoimmune/inflammatory conditions. They have been found in various chronic inflammatory diseases and are proposed to play a role in both pathogenic and regulatory functions. The heterogeneity and plasticity of DNT cells need to be further understood to explore potential therapeutic interventions.

CURRENT OPINION IN RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study

X. Xiao, G. Da, X. Xie, X. Liu, L. Zhang, B. Zhou, H. Li, P. Li, H. Yang, H. Chen, Y. Fei, G. C. Tsokos, L. Zhao, X. Zhang

Summary: SLE patients with concomitant TB exhibited distinct clinical characteristics compared to controls, including higher frequency of involvement in hematologic, mucocutaneous, and musculoskeletal systems, prior treatment with potent glucocorticoid/immunosuppressive agents, and an increased risk of miliary TB and intracranial TB in patients with lupus before TB infection. Lymphocytopenia was associated with poorer outcomes in SLE/TB + patients.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Rheumatology

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus

Bei-di Chen, Xin-Miao Jia, Jia-Yue Xu, Li-Dan Zhao, Jun-Yi Ji, Bing-Xuan Wu, Yue Ma, Hao Li, Xiao-Xia Zuo, Wen-You Pan, Xiao-Han Wang, Shuang Ye, George C. Tsokos, Jun Wang, Xuan Zhang

Summary: The study revealed significant differences in microbial composition and function in the gut microbiota of SLE patients compared to healthy controls, with certain species enriched in SLE patients and reduced after treatment. The findings were consistent in mice, and some species with an oral microbiota origin were enriched in the gut of SLE patients.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Multidisciplinary Sciences

Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance

Junwei Zeng, Rajindra P. Aryal, Kathrin Stavenhagen, Chi Luo, Renyan Liu, Xiaohui Wang, Jiaxuan Chen, Hao Li, Yasuyuki Matsumoto, Yingchun Wang, Jianmei Wang, Tongzhong Ju, Richard D. Cummings

Summary: Deficiency in Cosmc leads to disruption of B cell tolerance, resulting in the development of autoimmune pathologies characterized by elevated levels of self-reactive antibodies, enhanced basal activation, and increased frequency of spontaneous germinal center B cells.

SCIENCE ADVANCES (2021)

Article Immunology

Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies

Hao Li, Afroditi Boulougoura, Yushiro Endo, George C. Tsokos

Summary: T cell abnormalities are closely associated with the development of SLE, including numerical and functional disturbances in CD4+ and CD8+ T cells, which lead to immune dysregulation and tissue infiltration. These abnormalities are mainly due to signaling defects, metabolic alterations, and epigenetic changes. Novel strategies to correct T cell abnormalities show promise for SLE treatment.

JOURNAL OF AUTOIMMUNITY (2022)

Article Multidisciplinary Sciences

CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy

Ping-Min Chen, Eri Katsuyama, Abhigyan Satyam, Hao Li, Jose Rubio, Sungwook Jung, Sylvia Andrzejewski, J. David Becherer, Maria G. Tsokos, Reza Abdi, George C. Tsokos

Summary: CD38 up-regulation in CD8(+) T cells of SLE patients negatively affects T cell function by inhibiting mitochondrial fitness and mitophagy. Targeted administration of a CD38 inhibitor improves T cell function and viral clearance, suggesting CD38 as a potential therapeutic target to mitigate infection rates in people with SLE.

SCIENCE ADVANCES (2022)

Correction Urology & Nephrology

The immunoregulatory roles of non-haematopoietic cells in the kidney ( nov 2023 ,10.1038/s41581-023-00786-x)

George C. Tsokos, Afroditi Boulougoura, Vivek Kasinath, Yushiro Endo, Reza Abdi, Hao Li

NATURE REVIEWS NEPHROLOGY (2023)

Review Urology & Nephrology

The immunoregulatory roles of non-haematopoietic cells in the kidney

George C. Tsokos, Afroditi Boulougoura, Vivek Kasinath, Ushiro Endo, Reza Abdi, Hao Li

Summary: The immune cells and parenchymal cells in the kidney play a significant role in the induction of kidney damage. Kidney parenchymal cells provide structural immunity to the kidney through the regulation of immune-relevant processes, affecting kidney inflammation and injury. Targeted drug delivery to kidney parenchymal cells holds promise for preventing or reversing inflammation in specific forms of kidney injury and disease.

NATURE REVIEWS NEPHROLOGY (2023)

Article Medicine, Research & Experimental

IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation

Hao Li, Maria G. Tsokos, Rhea Bhargava, Iannis E. Adamopoulos, Hanni Menn-Josephy, Isaac E. Stillman, Philip Rosenstiel, Jarrat Jordan, George C. Tsokos

Summary: The study found that IL-23 can affect renal tubular epithelial cells by inhibiting the expression of IL-23 receptor, increasing the levels of free arginine, suppressing T cell proliferation, and inflammatory cytokine production. The results suggest that renal tubular epithelial cells play an immunosuppressive role in regulating kidney inflammation.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Allergy

IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases

Hao Li, George C. Tsokos

Summary: Inflammatory rheumatic disorders involve the immune system attacking connective tissues and internal organs. Advances in understanding the cellular and molecular mechanisms have led to targeting the IL-23/IL-17 axis therapeutically, resulting in clinical benefits. The complicated interrelationship between IL-23 and IL-17 may be uncoupled in certain disease settings.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Serine/threonine phosphatase PP2A is essential for optima B cell function

Esra Meidan, Hao Li, Wenliang Pan, Michihito Kono, Shuilian Yu, Vasileios C. Kyttaris, Christina Ioannidis, Noe Rodriguez Rodriguez, Jose C. Crispin, Sokratis A. Apostolidis, Pui Lee, John Manis, Amir Sharabi, Maria G. Tsokos, George C. Tsokos

JCI INSIGHT (2020)

Article Medicine, Research & Experimental

PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development

Amir Sharabi, Hao Li, Isaac R. Kasper, Wenliang Pan, Esra Meidan, Maria G. Tsokos, Vaishali R. Moulton, George C. Tsokos

JCI INSIGHT (2019)

No Data Available